Markers for gastric cancer premalignant lesions: where do we go? - Wikidata - wikimedia - TriplyDB

Markers for gastric cancer premalignant lesions: where do we go?

Markers for gastric cancer premalignant lesions: where do we go?

http://www.wikidata.org/entity/Q38020730

about

May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.Metachronous gastric cancer after successful Helicobacter pylori eradication.Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.miRNA: The nemesis of gastric cancer (Review).Biomarkers of Helicobacter pylori-associated gastric cancer.The chemokine receptor CXCR4 is associated with the staging of gastric cancer.MicroRNAs in gastric cancer: from benchtop to bedside.MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.Nuclear pattern of CXCR4 expression is associated with a better overall survival in patients with gastric cancer.miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.

P2860

Q26780339-FC6584F2-7B93-4647-88F2-EDB3D2269734 Q33626437-BDE7A9DF-0C3E-43A7-A5D1-34A3A8E1565C Q33927576-9B15A35C-EC7D-458A-B65D-53C63E186695 Q34137273-E4171821-1B67-4C6E-B94A-A6678FE2665F Q34750616-87C1CC3F-780A-42C8-8907-98D7484D8731 Q37211784-781B5BF0-6761-4048-8B9C-4F730D18276A Q37591506-96CADDC8-4BA9-4177-8A77-C3063BEAB916 Q37592605-FAC166FA-0690-4017-9DD3-47587C63A734 Q38151490-4148D41A-F280-4FE2-A4C3-1A5DEC438FB3 Q38926425-ACE30014-9DF8-4D4E-AD7C-4A9616EE2036 Q39012611-E2DDD2C3-CFF0-42BB-8D9D-E6370E777BFC Q39091716-64E7E9B1-4EAF-464E-881C-1585FCEE0A6F Q39221459-DCEA8DF3-A766-45D6-8420-E5A7A59BE8F8

P2860

Markers for gastric cancer premalignant lesions: where do we go?

http://www.wikidata.org/entity/Q38020730

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Markers for gastric cancer premalignant lesions: where do we go?

@en

type

label

Markers for gastric cancer premalignant lesions: where do we go?

@en

prefLabel

Markers for gastric cancer premalignant lesions: where do we go?

@en

P1433

Q38020730-F207E0A0-2C82-446A-8E60-A1064527749F

P1476

Q38020730-B611C122-AF78-4C69-BF9C-13243717F0C6

P2093

Q38020730-91C5BC9B-7ABD-4E22-A190-5D7E70F1A662

Q38020730-CEA23ED0-CC8D-4CB2-9FCB-1198A7F42D7A

P2860

Q38020730-01287BE8-3AD1-43F3-8A91-5A2C8AA0A361

Q38020730-018F63C6-226F-4AA8-B6A2-8C85E5383FF4

Q38020730-02F14927-B759-4440-87CD-9BF8F4A720BA

Q38020730-046EFE56-ED95-464E-8FB0-59F491C0BFE5

Q38020730-063F538C-51E9-4F96-8A02-63B4B6F82DD8

Q38020730-0964A5F1-F96E-4722-981B-9352300C5F00

Q38020730-0DED5206-D89E-44D9-B405-030F647D035F

Q38020730-129CECE4-A3CF-48B8-9327-E52E04749487

Q38020730-18381861-AFCA-4953-AA46-6A4435632839

Q38020730-1CF00346-DBB4-4F5B-8CCB-6ACA0F4B7341

P304

Q38020730-8C503F7E-C038-43FA-8357-50717BD0FB09

P31

Q38020730-75725B66-BFB7-4426-B5DA-482E7FB24292

P356

Q38020730-C58974E8-EA1C-446D-9AA0-0B6258A3CA98

P433

Q38020730-BCA4E286-CFC5-42BD-891F-AA256B7CEDC5

P478

Q38020730-1C4E00E8-27C2-4838-9E19-FF4DFA908CF0

P50

Q38020730-D7CC2B71-338A-44A1-9380-A6CB4EC22AF6

P577

Q38020730-90632713-90B8-44EF-A0CE-62062597DF88

P698

Q38020730-CFFB69F3-8DBB-4728-A9B7-661AC5196F13

P356

P1433

Digestive Diseases

P1476

Markers for gastric cancer premalignant lesions: where do we go?

@en

P2093

Marcis Leja

http://www.w3.org/2001/XMLSchema#string

Thomas Wex

http://www.w3.org/2001/XMLSchema#string

P2860

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

Global cancer statistics, 2002

The functions of animal microRNAs

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia

Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians

Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications.

A molecular signature of gastric metaplasia arising in response to acute parietal cell loss

P304

268-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000336990

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Peter Malfertheiner

P577

2012-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22722551

http://www.w3.org/2001/XMLSchema#string